 Virginia Sarapura
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycoprotein Hormones, alpha Subunit | 10 | 2006 | 22 | 0.900 |
Why?
| | Pituitary Neoplasms | 9 | 2006 | 157 | 0.500 |
Why?
| | Promoter Regions, Genetic | 8 | 1998 | 1131 | 0.370 |
Why?
| | Thyrotropin | 10 | 1998 | 99 | 0.370 |
Why?
| | Triiodothyronine | 4 | 2005 | 42 | 0.300 |
Why?
| | Transcription Factors | 6 | 2006 | 1528 | 0.290 |
Why?
| | Thyrotropin, beta Subunit | 1 | 2006 | 5 | 0.260 |
Why?
| | Receptors, Thyroid Hormone | 2 | 1997 | 20 | 0.250 |
Why?
| | Pituitary Gland | 3 | 1998 | 148 | 0.240 |
Why?
| | Thyroid Neoplasms | 4 | 2010 | 264 | 0.190 |
Why?
| | Thyroxine | 3 | 2001 | 56 | 0.190 |
Why?
| | Transfection | 10 | 2005 | 866 | 0.170 |
Why?
| | Thyroiditis, Autoimmune | 2 | 2017 | 13 | 0.170 |
Why?
| | Homeodomain Proteins | 4 | 2005 | 463 | 0.160 |
Why?
| | Gene Expression | 4 | 1998 | 1421 | 0.160 |
Why?
| | Graves Disease | 1 | 2017 | 32 | 0.150 |
Why?
| | Thyroid Gland | 1 | 2017 | 82 | 0.140 |
Why?
| | Tumor Cells, Cultured | 8 | 1998 | 849 | 0.130 |
Why?
| | Gene Expression Regulation | 5 | 1998 | 2319 | 0.120 |
Why?
| | RNA, Messenger | 5 | 2005 | 2552 | 0.110 |
Why?
| | Transcription, Genetic | 6 | 2002 | 1313 | 0.110 |
Why?
| | Hyperprolactinemia | 1 | 1993 | 4 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2017 | 766 | 0.100 |
Why?
| | Mice | 17 | 2006 | 14863 | 0.100 |
Why?
| | Blotting, Northern | 6 | 2002 | 193 | 0.100 |
Why?
| | DNA, Complementary | 2 | 2006 | 256 | 0.100 |
Why?
| | Luciferases | 3 | 1998 | 142 | 0.100 |
Why?
| | Thyroid Diseases | 1 | 2010 | 30 | 0.090 |
Why?
| | Nuclear Proteins | 3 | 2005 | 591 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1737 | 0.090 |
Why?
| | Base Sequence | 5 | 1998 | 2114 | 0.090 |
Why?
| | Receptors, Somatostatin | 2 | 2001 | 24 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 1990 | 487 | 0.080 |
Why?
| | Molecular Sequence Data | 5 | 1998 | 2785 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2005 | 1141 | 0.080 |
Why?
| | MSX1 Transcription Factor | 2 | 1998 | 4 | 0.080 |
Why?
| | Animals | 18 | 2010 | 31699 | 0.080 |
Why?
| | RNA, Neoplasm | 2 | 2005 | 80 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 3 | 1998 | 151 | 0.070 |
Why?
| | Precision Medicine | 1 | 2010 | 337 | 0.070 |
Why?
| | Pituitary Gland, Anterior | 3 | 1998 | 39 | 0.070 |
Why?
| | Receptors, Thyrotropin | 1 | 2006 | 1 | 0.070 |
Why?
| | DNA | 6 | 1998 | 1352 | 0.060 |
Why?
| | Thyroid Hormones | 2 | 2002 | 53 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2005 | 740 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 923 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 351 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2006 | 2568 | 0.050 |
Why?
| | Mice, Inbred C57BL | 4 | 2006 | 4692 | 0.050 |
Why?
| | Cell Line | 3 | 1997 | 2636 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1998 | 345 | 0.040 |
Why?
| | Binding Sites | 3 | 1998 | 1168 | 0.040 |
Why?
| | Gonadotropins, Pituitary | 1 | 1998 | 22 | 0.040 |
Why?
| | Paired Box Transcription Factors | 1 | 1998 | 36 | 0.040 |
Why?
| | Hypothyroidism | 4 | 2002 | 64 | 0.040 |
Why?
| | Mutagenesis | 1 | 1998 | 168 | 0.040 |
Why?
| | B7-2 Antigen | 1 | 2017 | 25 | 0.040 |
Why?
| | Deoxyribonuclease I | 1 | 1997 | 34 | 0.040 |
Why?
| | Consensus Sequence | 1 | 1997 | 70 | 0.040 |
Why?
| | Cell Nucleus | 2 | 1998 | 554 | 0.040 |
Why?
| | Clonal Anergy | 1 | 2017 | 53 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 1998 | 372 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 1997 | 993 | 0.040 |
Why?
| | Blotting, Southern | 1 | 1997 | 68 | 0.040 |
Why?
| | Gene Library | 1 | 1997 | 114 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1997 | 104 | 0.040 |
Why?
| | Gene Deletion | 1 | 1998 | 356 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1997 | 522 | 0.030 |
Why?
| | Plasmids | 1 | 1997 | 343 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2017 | 323 | 0.030 |
Why?
| | Epitopes | 1 | 2017 | 435 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2017 | 3885 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1037 | 0.030 |
Why?
| | Pergolide | 1 | 1993 | 1 | 0.030 |
Why?
| | Bromocriptine | 1 | 1993 | 26 | 0.030 |
Why?
| | Prolactin | 1 | 1993 | 96 | 0.030 |
Why?
| | Receptors, Dopamine D2 | 1 | 1993 | 86 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 1993 | 228 | 0.030 |
Why?
| | Basophils | 1 | 1992 | 64 | 0.020 |
Why?
| | DNA-Binding Proteins | 2 | 1998 | 1314 | 0.020 |
Why?
| | Restriction Mapping | 1 | 1990 | 77 | 0.020 |
Why?
| | Graves Ophthalmopathy | 1 | 2010 | 14 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1990 | 81 | 0.020 |
Why?
| | Autoantibodies | 1 | 2017 | 1346 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2010 | 39 | 0.020 |
Why?
| | Genes | 1 | 1990 | 223 | 0.020 |
Why?
| | Mice, Transgenic | 3 | 1998 | 1947 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 2001 | 3046 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2010 | 382 | 0.020 |
Why?
| | Organ Specificity | 2 | 1998 | 268 | 0.020 |
Why?
| | Humans | 7 | 2017 | 114662 | 0.020 |
Why?
| | Genes, cdc | 1 | 2005 | 10 | 0.020 |
Why?
| | Wnt Proteins | 1 | 2005 | 134 | 0.010 |
Why?
| | Cattle | 2 | 1998 | 921 | 0.010 |
Why?
| | Female | 4 | 2017 | 59493 | 0.010 |
Why?
| | Down-Regulation | 1 | 2005 | 594 | 0.010 |
Why?
| | Male | 5 | 2017 | 55583 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 292 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 163 | 0.010 |
Why?
| | Signal Transduction | 1 | 1993 | 4512 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 758 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1993 | 9088 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1518 | 0.010 |
Why?
| | Fushi Tarazu Transcription Factors | 1 | 1998 | 5 | 0.010 |
Why?
| | Steroidogenic Factor 1 | 1 | 1998 | 6 | 0.010 |
Why?
| | Sequence Homology | 1 | 1998 | 39 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 2710 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2002 | 551 | 0.010 |
Why?
| | Sequence Deletion | 1 | 1998 | 167 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2001 | 1629 | 0.010 |
Why?
| | Transgenes | 1 | 1998 | 170 | 0.010 |
Why?
| | Autoradiography | 1 | 1997 | 70 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 8632 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1997 | 34 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 192 | 0.010 |
Why?
| | RNA | 1 | 2001 | 809 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 723 | 0.010 |
Why?
| | Hyperthyroidism | 1 | 1994 | 26 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1994 | 62 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1994 | 286 | 0.010 |
Why?
| | Transcription Factor Pit-1 | 1 | 1993 | 24 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 1994 | 169 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 1 | 1994 | 216 | 0.010 |
Why?
| | Apoptosis | 1 | 2002 | 2362 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1994 | 616 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1993 | 385 | 0.010 |
Why?
| | Blotting, Western | 1 | 1993 | 1147 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1990 | 152 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1990 | 666 | 0.000 |
Why?
|
|
Sarapura's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|